Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59,764
+$46,125 QoQ
Shares Held
49,804
+257.8% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 43.422215083125856.ToString("F0")%
Shared 0.ToString("F0")%
None 56.57778491687415.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MERCER GLOBAL ADVISORS INC /ADV holds $216,657,489 across 109 Biotechnology names. FATE ranks #91 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
831,428 | $69,981,294 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
802,470 | $39,361,153 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,053 | $15,493,749 | |
| 4 | CAPR |
Capricor Therapeutics, Inc.
|
402,999 | $12,251,169 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,762 | $10,164,143 | |
| 6 | INCY |
Incyte Corp
|
93,266 | $8,778,195 | |
| 7 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,910,540 | $6,495,836 | |
| 8 | EXEL |
Exelixis, Inc.
|
136,747 | $5,865,078 |
All Filings in FATE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,764 | 49,804 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,639 | 13,918 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $20,635 | 16,377 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||